SCHEMBL2872056

SCHEMBL2872056

CC(C)COC(=O)C[C@@H](O)c1cccs1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
TSHR P16473 2/20 0.41
ALOX5 P09917 1/20 0.40
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
KEAP1 Q14145 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
ADORA2B P29275 1/20 0.39
ALOX12 P18054 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 2/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2865884 1.00 ALDH1A1 (0.41) ALDH1A1TSHRALOX5RAB9ANPC1
SCHEMBL2865878 1.00 ALDH1A1 (0.41) ALDH1A1TSHRALOX5RAB9ANPC1
SCHEMBL2859012 0.85 ALDH1A1 (0.43) ALDH1A1TSHRALOX5RAB9ASMN1; SMN2
SCHEMBL2859011 0.85 ALDH1A1 (0.43) ALDH1A1TSHRALOX5RAB9ASMN1; SMN2
SCHEMBL2867866 0.85 ALDH1A1 (0.43) ALDH1A1TSHRALOX5RAB9ASMN1; SMN2
SCHEMBL2871207 0.82 CES2 (0.40) ALDH1A1TSHRALOX5RAB9ANPC1
SCHEMBL2871203 0.82 CES2 (0.40) ALDH1A1TSHRALOX5RAB9ANPC1
SCHEMBL2872072 0.82 CES2 (0.40) ALDH1A1TSHRALOX5RAB9ANPC1
SCHEMBL2874009 0.82 TSHR (0.42) ALDH1A1TSHRALOX5RAB9ANPC1
SCHEMBL2866024 0.82 TSHR (0.42) ALDH1A1TSHRALOX5RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7659409-B2 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2010-02-09 US disclosed
US-20050107621-A1 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same MITSUBISHI CHEMICAL CORPORATION (JP) 2005-05-19 US disclosed
EP-1486493-A1 3-HYDROXY-3-(2-THIENYL)PROPIONAMIDE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING 3-AMINO-1-(2-THIENYL)-1-PROPANOL COMPOUND THEREFROM Mitsubishi Chemical Corporation (JP) 2004-12-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107621-A1 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same APEH, AADAC, KMO ALDH1A1 174/4885TSHR 879/4885ALOX5 286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.